When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRNX - Crinetics Pharmaceuticals begins early-stage study of CRN01941 for NETs
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals (NASDAQ:CRNX) has initiated Phase 1, placebo-controlled, single- and multiple-dose study to evaluate the safety, pharmacokinetics, and pharmacodynamics of CRN01941 in healthy volunteers.
More news on: Crinetics Pharmaceuticals, Inc., Healthcare stocks news,